Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.

“This agreement continues a longstanding collaboration between Merck and Syapse and is a testament to the growing power of real-world evidence and the position that Syapse has established as a leader in the oncology space,” said Ken Tarkoff, CEO of Syapse. “We have grown and expanded our footprint, forging relationships with health systems and cancer centers across the country to provide access to high-quality, real-world data to deliver the right care for patients.”

Merck will utilize Syapse’s real-world data platform across multiple tumor types with a focus on better understanding the critical stage in the patient journey leading up to a diagnosis and beginning treatment.

Syapse’s network enables improved cancer care through collaboration and real-world evidence. Whereas the limitations of traditional, individual data sources present challenges to deriving trustworthy insights from RWD, Syapse’s proprietary multi-source data strategy approach enables partners to gain a high-fidelity view of the oncology landscape that can be actionable to improve patient care. Syapse’s approach validates that, although every dataset has a limitation, with collaboration, there is a way to realize the full potential of RWD.

About Syapse®

Syapse is a company dedicated to extinguishing the fear and burden of oncology and other serious diseases by advancing real-world care. By marrying clinical expertise with smart technologies, we transform data into evidence—and then into the experience—in collaboration with our network of partners, who are committed to improving patients’ lives through community health systems. Together, we connect comprehensive patient insights to our network to empower our partners in driving real impact and improving access to high-quality care.

Syapse Contact
Christian Edgington, Media & Engagement  
cedgington@realchemistry.com  

Staff

Recent Posts

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

29 minutes ago

purelyIV Launches Mobile App for Seamless Wellness Management

The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…

29 minutes ago

Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…

30 minutes ago

Largest Virginia FQHC Leverages eClinicalWorks and Sunoh.ai to Witness Significant Time-Savings and Reduced Physician Burnout

eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…

6 hours ago